Literature DB >> 3550147

Complications of ureteral endoscopy.

B Lytton, R M Weiss, D F Green.   

Abstract

Use of the rigid ureterorenoscope has become widely accepted for the diagnosis of ureteral lesions, and for the removal and disintegration of ureteral calculi. Few complications have been reported. During the last 3 years 128 ureteroscopic procedures were performed for a variety of indications (98 for stone disease). There were 26 complications: 22 minor with no morbidity and 4 major that required surgical correction. Minor complications consisted of asymptomatic ureteral perforations in 6 patients, perforations with urinary extravasation, pain, ileus or fever in 4, migration of the stone into the kidney in 10 and migration of the stone outside the ureter with the calculus left in situ in 2. Major complications included ureteral perforation during basket extraction of an upper ureteral stone, urinoma following perforation and requiring drainage, stenosis of the intramural ureter that was corrected by marsupialization and aseptic necrosis of the ureter that was treated by ileal replacement.

Entities:  

Mesh:

Year:  1987        PMID: 3550147     DOI: 10.1016/s0022-5347(17)44165-6

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  3 in total

1.  Retrograde ureterorenoscopy in the management of ureteral calculi.

Authors:  M Amin el-Baz
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

2.  Categorization of intraoperative ureteroscopy complications using modified Satava classification system.

Authors:  Abdulkadir Tepeler; Berkan Resorlu; Tolga Sahin; Selcuk Sarikaya; Mirze Bayindir; Ural Oguz; Abdullah Armagan; Ali Unsal
Journal:  World J Urol       Date:  2013-03-17       Impact factor: 4.226

3.  Safety and efficacy of silodosin and tadalafil in ease of negotiation of large ureteroscope in the management of ureteral stone: A prosective randomized trial.

Authors:  Rohit Bhattar; Vipin Jain; Vinay Tomar; Sher Singh Yadav
Journal:  Turk J Urol       Date:  2017-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.